VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BSVN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BSVNBank7 Corp.
$58.39$556M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBSVNBalance Sheet

Bank7 Corp. (BSVN) Balance Sheet

10Y historyFree accessUpdated daily

The balance sheet appears well-capitalized with equity-to-assets improving from 0.10 to 0.14 and total assets reaching $2.0B, yet ROE simultaneously halved from 6.4% to 3.8% and the investment securities portfolio swung from $52.1M (2026Q1) to $1.7B (2026Q3), raising questions about capital deployment efficiency and portfolio classification stability.

Income StatementBalance SheetCash FlowRatios

BSVN Balance Sheet

Annual statement

BSVN Balance Sheet

Bank7 Corp. (BSVN) balance sheet — 10-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Cash & Short Term Investments1.15B255.09M273.14M338.41M287.75M283.4M170.31M147.28M159.85M130.22M103.67M
Cash & Due from Banks277.18M244.63M240.91M198.72M114.59M198.6M170.31M147.28M159.85M130.22M103.67M
Short Term Investments47.54M10.46M32.22M139.69M173.16M84.81M00000
Total Investments1.66B65.64M1.41B1.48B1.43B1.1B828.47M701.59M593.64M556.78M496.81M
Investments Growth %-282.81%-95.35%-4.71%3.69%29.47%33.33%18.08%18.18%6.62%12.07%-
Long-Term Investments1.67B55.18M1.38B1.34B1.26B1.02B828.47M701.59M593.64M556.78M496.81M
Accounts Receivables000016.44M10.52M7.15M6.12M7.16M4.68M4.27M
Goodwill & Intangibles11.87M11.96M9.34M9.49M9.94M10.12M1.58M1.79M2M2.2M2.41M
Goodwill11.21M11.21M8.46M8.46M8.6M8.48M1.01M1.01M1.01M1.01M1.01M
Intangible Assets658K752K878K1.03M1.34M1.64M572K778K984K1.19M1.4M
PP&E (Net)27.13M21.88M18.14M14.94M13.11M17.26M9.15M9.62M7.75M9.6M6.51M
Other Assets25.7M-55.18M58.45M65.68M09.49M00110K100K103.44K
Total Current Assets327.39M298.65M273.14M338.41M304.19M293.93M177.47M153.39M167.01M134.91M107.94M
Total Non-Current Assets1.68B33.84M1.47B1.43B1.28B1.06B839.2M713M603.5M568.69M505.84M
Total Assets2.01B1.96B1.74B1.77B1.58B1.35B1.02B866.39M770.51M703.59M613.77M
Asset Growth %32.16%12.87%-1.8%11.84%17.3%32.84%17.35%12.44%9.51%14.63%-
Return on Assets (ROA)2.11%2.33%2.6%1.69%2.02%1.96%2.05%1%3.39%3.61%2.74%
Accounts Payable00009.71M5.67M3.84M8.43M4.23M2.99M2.68M
Total Debt0000000005.6M6.4M
Net Debt-277.18M-244.63M-240.91M-198.72M-114.59M-198.6M-170.31M-147.28M-159.85M-124.62M-97.27M
Long-Term Debt0000000005.6M6.4M
Short-Term Debt00000000000
Other Liabilities12.06M1.71B11.12M9.65M-1.05M008.43M4.23M00
Total Current Liabilities1.72B594K1.52B1.59B1.44B1.22B909.35M757.84M677.82M628.82M552.23M
Total Non-Current Liabilities12.06M1.71B11.12M9.65M-1.05M008.43M4.23M5.6M6.4M
Total Liabilities1.73B1.71B1.53B1.6B1.44B1.22B909.35M766.27M682.04M634.42M558.63M
Total Equity273.73M251M213.21M170.33M144.1M127.41M107.32M100.13M88.47M69.18M55.14M
Equity Growth %63.03%17.72%25.18%18.2%13.1%18.72%7.18%13.18%27.89%25.46%-
Equity / Assets (Capital Ratio)13.64%12.78%12.25%9.61%9.1%9.43%10.56%11.56%11.48%9.83%8.98%
Return on Equity (ROE)15.74%18.56%23.83%17.99%21.83%19.73%18.57%8.7%31.72%38.27%30.5%
Book Value per Share28.3926.2222.5718.3915.6514.0111.449.8710.746.795.41
Tangible BV per Share27.1624.9721.5817.3614.5712.9011.279.6910.506.575.18
Common Stock95K95K94K92K91K91K90K101K102K73K72.88K
Additional Paid-in Capital104.58M103.74M101.81M97.42M95.26M94.02M93.16M92.39M80.28M6.99M6.99M
Retained Earnings172.26M149.71M116.28M78.96M58.05M33.15M14.07M7.61M8.09M62.12M48.08M
Accumulated OCI-3.21M-2.55M-4.97M-6.14M-9.3M144K00000
Treasury Stock00000000000
Preferred Stock00000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

ROE Erosion Despite Equity Buildup

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Capital Ratio Expansion Masking Returns Erosion

According to recent SEC filings, Bank7's equity-to-assets ratio climbed from 0.10 in 2024Q1 to 0.14 in 2026Q3—a 40% improvement—yet ROE simultaneously fell from 6.4% to 3.8%, suggesting the bank is accumulating capital faster than it can deploy it profitably.

The steady equity build from $180.4M to $273.7M over ten quarters appears to reflect retained earnings accumulation with minimal capital return, consistent with negligible share repurchases and rising dividend payments. While the 14% equity/assets ratio provides a meaningful buffer against credit losses, the inverse relationship between rising capital and falling ROE suggests the balance sheet may be becoming over-capitalized relative to its earning-asset base. Investors should monitor whether management articulates a clearer capital deployment framework, as idle capital at a sub-4% ROE environment may signal strategic indecision rather than prudential conservatism.

Securities Portfolio Volatility Raises Structural Questions

As reported in financial statements, Bank7's investment securities portfolio swung from $1.6B in 2025Q3 to just $52.1M in 2026Q1 before rebounding to $1.7B in 2026Q3—a pattern suggesting either significant portfolio restructuring or classification shifts that warrants careful analyst scrutiny.

The dramatic reduction and subsequent re-emergence of the securities portfolio across these three quarters is among the most unusual patterns in the ten-quarter dataset, as the balance sheet simultaneously shows stable total assets near $1.9-2.0B. This oscillation, when combined with the cash position ranging between $218M and $277M, suggests the bank may have engaged in temporary repositioning of its earning-asset mix rather than a sustained strategic shift. The lack of corresponding swings in total assets implies offsetting movements elsewhere on the balance sheet that the summary data does not fully illuminate, and investors should seek additional disclosure to understand what drove this allocation change.

Balance Sheet Growth Decoupled from Earnings Power

Based on EDBL's reported figures, Bank7's total assets grew approximately 11% from $1.8B in 2024Q1 to $2.0B in 2026Q3, yet net interest income declined from $22.0M to $22.3M and NIM compressed from 1.2% to 1.1%, indicating the incremental balance sheet is generating diminishing marginal returns.

The asset growth appears to have come disproportionately from funding-side expansion rather than loan deployment, as the consistent absence of the loan-to-deposit ratio metric limits visibility into whether the loan book is keeping pace with deposit growth. The equity base expanded 52% over the period while NII barely moved, which mechanically depresses ROE from 6.4% to 3.8% and suggests the bank's earning-asset yield is not scaling with its expanding capital base. This decoupling of balance sheet size from earnings power, if it persists, would represent a meaningful challenge to the franchise's long-term value creation trajectory.

NIM Compression Signals Structural Margin Headwinds

According to recent SEC filings, Bank7's net interest margin drifted from a peak of 1.3% in 2024Q2 to 1.1% by 2026Q3, a 20 basis point compression that coincided with an efficiency ratio deterioration from 37.5% to 41.7%, suggesting both asset and liability repricing pressures are converging unfavorably.

The NIM compression from 1.3% to 1.1% appears to reflect a structural repricing dynamic where the bank's loan and securities yields are adjusting more slowly than its cost of deposits—a pattern consistent with a growing and potentially stickier funding base. With efficiency ratio worsening simultaneously, the bank faces a dual squeeze that may constrain operating leverage even if the loan book continues growing. Given the minimal provisioning observed across the period, there may be limited cost relief from credit normalization, meaning NIM trajectory will likely be the primary driver of forward earnings power.

Capital Efficiency Paradox Defies Simple Narrative

The most counterintuitive balance sheet dynamic at Bank7 is that equity grew 52% and the equity-to-assets ratio improved 40% over ten quarters, yet ROE halved from 6.4% to 3.8%—suggesting the capital accumulation itself may be the mechanism destroying per-share returns rather than a sign of strength.

Conventional analysis would celebrate the 14% equity/assets ratio as a fortress indicator, but the concurrent ROE compression and NIM decline suggest the bank may be hoarding capital without an identifiable deployment pathway—a pattern more consistent with strategic uncertainty than prudent risk management. The single $700K provision in 2025Q3, against nearly $274M of equity, represents a provision-to-equity ratio of roughly 0.25%, which while indicative of a clean credit book also raises questions about whether reserve levels are calibrated to a normalizing rather than benign credit environment. If credit costs do rise from near-zero levels while NIM continues compressing, the already-deteriorating returns on equity could face compounding pressure from both sides, potentially triggering a reassessment of the premium the market may assign to this capital position.

BSVN — Frequently Asked Questions

Quick answers to the most common questions about buying BSVN stock.

What are the total assets of Bank7 Corp. (BSVN)?

As of 2025, Bank7 Corp. (BSVN) had total assets of $1.96B including $298.7M in current assets.

How much debt does Bank7 Corp. (BSVN) have?

Bank7 Corp. (BSVN) carries total debt of $0.0M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Bank7 Corp.?

Bank7 Corp. (BSVN) has total shareholders' equity (book value) of $251.0M ($26.22 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Bank7 Corp.'s current ratio and liquidity?

Bank7 Corp. (BSVN) reported a current ratio of 502.78x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.